TRIAMCINOLONE , VANCOMYCIN , CEFAZOLIN , BETAMETHASONE , OMEPRAZOLE , JNJ-74765340, JNJ-74765340, DEXAMETHASONE , CEFUROXIME
MGT-RPGR-022
Phase 3 small_molecule active
Quick answer
TRIAMCINOLONE , VANCOMYCIN , CEFAZOLIN , BETAMETHASONE , OMEPRAZOLE , JNJ-74765340, JNJ-74765340, DEXAMETHASONE , CEFUROXIME for X-Linked Retinitis Pigmentosa caused by mutations in the RPGR gene is a Phase 3 program (small_molecule) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen-Cilag International N.V.
- Indication
- X-Linked Retinitis Pigmentosa caused by mutations in the RPGR gene
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active